I call this meeting back to order.
We are resuming meeting number 23 of the House of Commons Standing Committee on Health. We are meeting today to study the emergency situation facing Canadians in light of the second wave of the COVID-19 pandemic.
I'd like to welcome the witnesses.
For this panel, we have Dr. Ève Dubé, researcher, Research Center, Université Laval; and Dr. Nathalie Grandvaux, professor, Université de Montréal. From Pfizer Canada we have Mr. Pinnow, president.
We will start with witness statements.
Dr. Dubé, please go ahead for six minutes.